Macquarie Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.75M Hold
330,100
0.01% 843
2025
Q1
$7.97M Sell
330,100
-187,308
-36% -$4.52M 0.01% 856
2024
Q4
$20.8M Sell
517,408
-50,992
-9% -$2.05M 0.03% 639
2024
Q3
$36M Sell
568,400
-306
-0.1% -$19.4K 0.04% 528
2024
Q2
$30.1M Buy
568,706
+91,771
+19% +$4.86M 0.03% 565
2024
Q1
$39.1M Buy
476,935
+146,835
+44% +$12M 0.04% 503
2023
Q4
$6.14M Hold
330,100
0.01% 915
2023
Q3
$3.65M Hold
330,100
﹤0.01% 1002
2023
Q2
$5.35M Hold
330,100
0.01% 910
2023
Q1
$5.5M Hold
330,100
0.01% 918
2022
Q4
$3.1M Hold
330,100
﹤0.01% 1081
2022
Q3
$898K Hold
330,100
﹤0.01% 1438
2022
Q2
$954K Sell
330,100
-1,948
-0.6% -$5.63K ﹤0.01% 1494
2022
Q1
$996 Hold
332,048
﹤0.01% 1549
2021
Q4
$1.53M Hold
332,048
﹤0.01% 1447
2021
Q3
$2.09M Hold
332,048
﹤0.01% 1372
2021
Q2
$1.99M Hold
332,048
﹤0.01% 1416
2021
Q1
$2.1M Sell
332,048
-597
-0.2% -$3.78K ﹤0.01% 1193
2020
Q4
$1.87M Hold
332,645
﹤0.01% 1124
2020
Q3
$1.94M Hold
332,645
﹤0.01% 1047
2020
Q2
$2.4M Buy
332,645
+2,545
+0.8% +$18.3K ﹤0.01% 957
2020
Q1
$1.55M Hold
330,100
﹤0.01% 979
2019
Q4
$2.65M Hold
330,100
﹤0.01% 957
2019
Q3
$2.27M Hold
330,100
﹤0.01% 984
2019
Q2
$2.74M Sell
330,100
-72,206
-18% -$599K ﹤0.01% 935
2019
Q1
$4M Sell
402,306
-35,594
-8% -$354K 0.01% 840
2018
Q4
$3.35M Buy
437,900
+61,100
+16% +$467K 0.01% 843
2018
Q3
$6.56M Buy
376,800
+46,700
+14% +$814K 0.01% 724
2018
Q2
$3.13M Buy
+330,100
New +$3.13M 0.01% 879
2018
Q1
Sell
-2,100
Closed -$9K 2373
2017
Q4
$9K Buy
+2,100
New +$9K ﹤0.01% 2282